Pharmacogenomics and drug responseMÜLLER, M.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 6, pp 231-240, issn 0946-1965, 10 p.Article

Pharmacokinetic-pharmacodynamic interrelationships of intravenous and oral levosimendan in patients with severe congestive heart failurePODER, P; EHA, J; SUNDBERG, S et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 8, pp 365-373, issn 0946-1965, 9 p.Article

Pharmacokinetics and pharmacodynamics of cisplatin after intra-operative Hyperthermic intraperitoneal chemoperfusion (HIPEC)ZEAMARI, S; FLOOT, B; VAN DER VANGE, N et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1643-1648, issn 0250-7005, 6 p.Article

Comparative in vivo evaluation of propranolol hydrochloride after oral and transdermal administration in rabbitsRAMA RAO, P; NARENDER REDDY, M; RAMAKRISHNA, Sistla et al.European journal of pharmaceutics and biopharmaceutics. 2003, Vol 56, Num 1, pp 81-85, issn 0939-6411, 5 p.Article

Pharmacokinetic and pharmacodynamic analysis of platinum after combined treatment of cisplatin and procainamide hydrochloride in mice bearing P388 leukemiaVANNOZZI, Maria O; OTTONE, Massimo; MARIGGIO, Maria A et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1509-1516, issn 0250-7005, 8 p.Article

Tissue concentrations : do we ever learn?MOUTON, Johan W; THEURETZBACHER, Ursula; CRAIG, William A et al.Journal of antimicrobial chemotherapy (Print). 2008, Vol 61, Num 2, pp 235-237, issn 0305-7453, 3 p.Article

Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjectsWOJCICKI, Jerzy; JAROSZYNSKA, Maria; DROZDZIK, Marek et al.Biopharmaceutics & drug disposition. 2003, Vol 24, Num 5, pp 211-218, issn 0142-2782, 8 p.Article

The hollow fibre model -facilitating anti-cancer pre-clinical pharmacodynamics and improving animal welfareSUGGITT, Marie; COOPER, Patricia A; SHNYDER, Steven D et al.International journal of oncology. 2006, Vol 29, Num 6, pp 1493-1499, issn 1019-6439, 7 p.Article

Tissue distribution and elimination of N-methyl-N-2,4,6-tetranitroaniline (tetryl) in ratsMYERS, Steven R; SPINNATO, Joseph A.Archives of toxicology. 2007, Vol 81, Num 12, pp 841-848, issn 0340-5761, 8 p.Article

Amino acid pharmacokinetics and safety assessmentBIER, Dennis M.The Journal of nutrition. 2003, Vol 133, Num 6, pp 2034-2039, issn 0022-3166, 6 p., SUP1Conference Paper

Pharmacokinetic-pharmacodynamic modelling : History and perspectivesCSAJKA, Chantal; VEROTTA, Davide.Journal of pharmacokinetics and pharmacodynamics (Print). 2006, Vol 33, Num 3, pp 227-279, issn 1567-567X, 53 p.Article

Modelling the genesis and treatment of cancer: The potential role of physiologically based pharmacodynamicsSTEIMER, Jean-Louis; DAHL, Svein G; FRIBERG, Lena E et al.European journal of cancer (1990). 2010, Vol 46, Num 1, pp 21-32, issn 0959-8049, 12 p.Article

Edoxaban administration following enoxaparin: A pharmacodynamic, pharmacokinetic, and tolerability assessment in human subjectsZAHIR, Hamim; MATSUSHIMA, Nobuko; HALIM, Abdel-Baset et al.Thrombosis and haemostasis. 2012, Vol 108, Num 1, pp 166-175, issn 0340-6245, 10 p.Article

In vitro and in vivo pharmacokinetic/ pharmacodynamic activity of clofoctolSCAGLIONE, Francesco; DUGNANI, Silvana; LUCINI, Valeria et al.Journal of chemotherapy (Testo stampato). 2012, Vol 24, Num 4, pp 201-206, issn 1120-009X, 6 p.Article

Interpreting population pharmacokinetic-pharmacodynamic analyses -a clinical viewpointDUFFULL, Stephen B; WRIGHT, Daniel F. B; WINTER, Helen R et al.British journal of clinical pharmacology. 2011, Vol 71, Num 6, pp 807-814, issn 0306-5251, 8 p.Article

Pharmacogenomics of antipsychotics efficacy for schizophreniaCACABELOS, Ramón; HASHIMOTO, Ryota; TAKEDA, Masatoshi et al.Psychiatry and clinical neurosciences (Carlton. Print). 2011, Vol 65, Num 1, pp 3-19, issn 1323-1316, 17 p.Article

Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclinesAGWUH, Kenneth N; MACGOWAN, Alasdair.Journal of antimicrobial chemotherapy (Print). 2006, Vol 58, Num 2, pp 256-265, issn 0305-7453, 10 p.Article

Class-dependent relevance of tissue distribution in the interpretation of anti-infective pharmacolcinetic/pharmacodynamic indicesBARBOUR, April; SCAGLIONE, Francesco; DERENDORF, Hartmut et al.International journal of antimicrobial agents (Print). 2010, Vol 35, Num 5, pp 431-438, issn 0924-8579, 8 p.Article

How Do We Use Drug Concentration Data to Improve the Treatment of Overdose Patients?ISBISTER, Geoffrey K.Therapeutic drug monitoring. 2010, Vol 32, Num 3, pp 300-304, issn 0163-4356, 5 p.Conference Paper

Nuclear receptors in herb―drug interactionsSACHAR, Madhav; XIAOCHAO MA.Drug metabolism reviews (Softcover ed.). 2013, Vol 45, Num 1, pp 73-78, issn 0360-2532, 6 p.Article

Introduction to haemostasis from a pharmacodynamic perspectiveKLUFT, Cornelis; BURGGRAAF, Jacobus.British journal of clinical pharmacology. 2011, Vol 72, Num 4, pp 538-546, issn 0306-5251, 9 p.Article

Antifungal serum concentration monitoring : an updateGOODWIN, Megan L; DREW, Richard H.Journal of antimicrobial chemotherapy (Print). 2008, Vol 61, Num 1, pp 17-25, issn 0305-7453, 9 p.Article

Differentiating Low-Molecular-Weight Heparins Based on Chemical, Biological, and Pharmacologic Properties : Implications for the Development of Generic Versions of Low-Molecular-Weight HeparinsJESKE, Walter P; WALENGA, Jeanine M; HOPPENSTEADT, Debra A et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, Num 1, pp 74-85, issn 0094-6176, 12 p.Article

Population approaches in paediatricsCHATELUT, Etienne.Fundamental & clinical pharmacology. 2008, Vol 22, Num 6, pp 575-578, issn 0767-3981, 4 p.Conference Paper

Pharmacodynamic Models for Discrete DataPAULE, Ines; GIRARD, Pascal; FREYER, Gilles et al.Clinical pharmacokinetics. 2012, Vol 51, Num 12, pp 767-786, issn 0312-5963, 20 p.Article